Abstract
Background: Several anti-malarial drugs are associated with adverse cardiovascular effects. There are a few reports available on the potential cardiac effects ( QTc interval) of artesunate, which includes an increased risk of potentially ventricular arrhythmia. This study aimed to evaluate the electrocardiographic (ECG) Changes (QTc interval ) in malaria patients treated with artesunate. Method: Total 32 (16 malea16 female ) patients with severe Falciparum malaria enrolled in medical ward, CIMS hospital Bilaspur (C.G) were selected. Electrocardiogram was recorded, and QTc interval was calculated before and after administration of three doses of artesunate given by intravenous injection in all patients who were positive for Falciparum malaria. Results: The mean QTc interval was not affected by intravenous artesunate (2.4 mg/kg) given at different time intervals(p>0.05). There was no significant effect observed on the JTc or PR interval, QRS width, blood pressure and heart rate. Intravenous artesunate does not have significant other cardiovascular effects in patients with severe Falciparum malaria. Conclusion: Intravenous artesunate does not have significant cardiovascular effects in patients with falciparum malaria.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
